Israel Englander Ab Cellera Biologics Inc. Call Options Transaction History

Millennium Management LLC

  • $207 Billion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 15, 2023
BUY
$7.31 - $11.18 $1.02 Million - $1.56 Million
139,100 Added 86.45%
300,000 $2.26 Million
Q4 2022

Feb 14, 2023
SELL
$9.48 - $14.52 $1.32 Million - $2.02 Million
-139,100 Reduced 46.37%
160,900 $1.63 Million
Q3 2022

Nov 14, 2022
BUY
$9.2 - $13.68 $2.76 Million - $4.1 Million
300,000 New
300,000 $2.97 Million

Others Institutions Holding ABCL

# of Institutions
169
Shares Held
110M
Call Options Held
239K
Put Options Held
200K
View Full List

About AbCellera Biologics Inc.

ABCL Quotes by TradingView
  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $787M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email